Skip to main content Skip to footer

Orexo press releases

Notice of Annual General Meeting in Orexo AB

23 March 2010 at 23:00 – RegulatoryGeneral Meeting

Notice of Annual General Meeting in Orexo AB

Notice of Extraordinary General Meeting

15 March 2010 at 08:00 – RegulatoryGeneral Meeting

Notice of Extraordinary General Meeting

Orexo AB (publ.) – Year-end Report January-December 2009

17 February 2010 at 08:00 – RegulatoryReportQ4

Orexo AB (publ.) – Year-end Report January-December 2009

Orexo confirms Canadian Regulatory Filing of Abstral

4 February 2010 at 12:00 – Regulatory

Orexo confirms Canadian Regulatory Filing of Abstral

Orexo AB (publ) – Interim report January-September 2009

10 November 2009 at 08:00 – RegulatoryReportQ3

Orexo AB (publ) – Interim report January-September 2009

Orexo confirms FDA acceptance of Abstral filing

6 October 2009 at 08:20 – Regulatory

Orexo confirms FDA acceptance of Abstral filing

New number of shares and votes in Orexo AB (publ)

31 August 2009 at 17:00 – Regulatory

New number of shares and votes in Orexo AB (publ)

Orexo AB (publ) – Interim report, January - June 2009

21 August 2009 at 08:45 – RegulatoryReportQ2

Orexo AB (publ) – Interim report, January - June 2009

Abstral™ file submitted to the FDA for approval in the USA

6 August 2009 at 08:30 – Regulatory

Abstral™ file submitted to the FDA for approval in the USA

Orexo announces that Abstral is ready for launch in France

30 June 2009 at 08:00 – Regulatory

Orexo announces that Abstral is ready for launch in France

Orexo AB (publ.) – Interim report, January-March 2009

6 May 2009 at 08:30 – RegulatoryReportQ1

Orexo AB (publ.) – Interim report, January-March 2009

Report from Orexo AB’s Annual General Meeting, 23 April 2009

23 April 2009 at 22:30 – RegulatoryGeneral Meeting

Report from Orexo AB’s Annual General Meeting, 23 April 2009

Orexo’s annual report for 2008 released

6 April 2009 at 12:00 – RegulatoryReport

Orexo’s annual report for 2008 released

Notice of Annual General Meeting of Orexo AB, 23 April 2009

25 March 2009 at 22:30 – RegulatoryGeneral Meeting

Notice of Annual General Meeting of Orexo AB, 23 April 2009

Orexo announces Phase IIa data on OX914 in rhinitis

24 March 2009 at 14:30 – Regulatory

Orexo announces Phase IIa data on OX914 in rhinitis

IR & Corporate Communications Director

Lena Wange

Subscribe